Peter Gilmour

Peter Gilmour, listed as board member, appears in our data through filings on Guard Therapeutics International AB (publ) shares, published by Finansinspektionen. The record holds 3 filings, for trades running from 12 May 2021 to 1 April 2025.

None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The latest filing, published on 1 April 2025, reports a transaction of €5,590 in Guard Therapeutics International AB (publ). Half of the filings or more reach the Finansinspektionen feed on the day of the trade. The regulation allows three business days to notify a trade (MAR article 19). Every figure here comes from the filings published by Finansinspektionen and describes the past, not future prices; it is not investment advice.